Expression profile of Japanese encephalitis virus induced neuroinflammation and its implication in disease severity

Journal of Clinical Virology

Volumn 49, Issue 1, 2010, Pages 4-10

  Gupta, Nimesh ^a   Lomash, Vinay ^a   Rao, P V Lakshmana ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Anti viral; Blood brain barrier; CLEC5A; Gene expression; Host response; MMP 9; Neuroinflammation; Real time PCR

Indexed keywords

CASPASE 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENCEPHALITIS; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY CELL; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; LEUKOCYTE; MACROPHAGE ACTIVATION; MEMBRANE PERMEABILITY; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPLEEN; UPREGULATION; VIRUS EXPRESSION; VIRUS LOAD;

EID: 77955661048     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.06.009     Document Type: Article

References (33)

1. Burke D.S., Monath T.P. Flaviviruses. Fields virology 2001, vol. 1:1043-1125. Lippincott Williams & Wilkins, Philadelphia. 4th ed.
2. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., Barrett A.D. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003, 77:3091-3098.
3. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand. Vaccine 2000, 26:1-25.
4. King N.J., Getts D.R., Getts M.T., Rana S., Shrestha B., Kesson A.M. Immunopathology of flavivirus infections. Immunol Cell Biol 2007, 85:33-42.
5. Burke D.S., Morill J.C. Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J Infect Dis 1987, 155:797-799.
6. Ravi V., Parida S., Desai A., Chandramukhi A., Gourie-Devi M., Grau G.E. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 1997, 51:132-136.
7. Winter P.M., Dung N.M., Loan H.T., Kneen R., Wills B., Thu T., et al. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 2004, 190:1618-1626.
8. Babu G.N., Kalita J., Misra U.K. Inflammatory markers in the patients of Japanese encephalitis. Neurol Res 2006, 28:190-192.
9. Appaiahgari M.B., Saini M., Rauthan M., Jyoti, Vrati S. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mouse against lethal encephalitis. Microbes Infect 2006, 8:92-104.
10. Vrati S., Agarwal V., Malik P., Wani S.A., Saini M. Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth. J Gen Virol 1999, 80:1665-1671.
11. Vrati S., Giri R.K., Razdan A., Malik P. Complete nucleotide sequence of an Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis. Am J Trop Med Hyg 1999, 61:677-680.
12. Bhowmick S., Duseja R., Das S., Appaiahgiri M.B., Vrati S., Basu A. Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett 2007, 414:45-50.
13. Santhosh S.R., Parida M.M., Dash P.K., Pateriya A., Pattnaik B., Pradhan H.K., et al. Development and evaluation of SYBR Green I-based one-step real time RT-PCR assay for detection and quantification of Japanese encephalitis virus. J Virol Methods 2007, 143:73-80.
14. -ΔΔCT method. Methods 2001, 25:402-408.
15. Chen S.T., Lin Y.L., Huang M.T., Wu M.F., Cheng S.C., Lei H.Y., et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453:672-678.
16. Solomon T., Dung N.M., Wills B., Kneen R., Gainsborough M., Diet T.V., et al. Interferon alfa-2a in Japanese encephalitis: a randomized double-blind placebo-controlled trial. Lancet 2003, 361:821-826.
17. Kumar R., Tripathi P., Baranwal M., Singh S., Tripathi S., Banerjee G. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin Infect Dis 2009, 48:400-406.
18. Hoke C.H., Nisalak A., Intralawan P., Poolsuppasit S., Jongsawas V., Titsyakorn U., et al. Effect of high dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992, 165:631-637.
19. Nakano A., Yamasaki R., Miyazaki S., Nobuaki H., Kunishige M., Mitsui T. Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur Neurol 2003, 50:225-229.
20. Gould E.A., Solomon T., Mackenzie J.S. Does antiviral therapy have a role in the control of Japanese encephalitis?. Antiviral Res 2008, 78:140-149.
21. Sebastian L., Desai A., Madhusudana S.N., Ravi V. Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin. Int J Antimicr Agents 2009, 33:168-173.
22. Stuve O., Dooley N.P., Uhm J.H. Interferron beta 1b decreases the migration of T lymphocytes in vitro; effects on matrix metalloproteinase-9. Ann Neurol 1996, 40:853-863.
23. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995, 154:4379-4389.
24. Agrawal S., Anderson P., Durbeej M., Van R.N., Ivars F., Opdenakker G. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasations in experimental autoimmune encephalomyelitis. J Exp Med 2006, 203:1007-1019.
25. Zozulya A.L., Reinke E., Baiu D.C., Karman J., Sandor M., Fabry Z. Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases. J Immunol 2007, 178:520-529.
26. Salmaggi A., Gelati M., Dufour A., Corsini E., Pagano S., Baccalini R. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J Interferon Cytokine Res 2002, 22:631-640.
27. Ishiguro A., Suzuki Y., Inaba Y., Fukushima K., Komiyama A., Koeffler H.P., et al. Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages. Clin Exp Immunol 1991, 86:299-303.
28. Gupta N., Santhosh S.R., Babu J.P., Parida M.M., Rao P.V.L. Chemokine profiling of Japanese encephalitis virus-infected mouse neuroblastoma cells by microarray and real time RT-PCR: implication in neuropathogenesis. Virus Res 2010, 147:107-112.
29. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005, 79:11457-11466.
30. MacEwan J.D. TNF ligands and receptors - a matter of life and death. Br J Pharma 2002, 135:855-875.
31. Yeh C.J., Lin P.Y., Liao M.H., Liu H.J., Lee J.W., Chiu S.J., et al. TNF-α mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling. Virology 2008, 381:55-66.
32. Lüschen S., Falk M., Scherer G., Ussat S., Paulsen M., Klages A.S. The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. Exp Cell Res 2005, 310:33-42.
33. Kogo J., Takeba Y., Kumai T., Kitaoka Y., Matsumoto N., Ueno S., et al. Involvement of TNF-alpha in glutamate-induced apoptosis in a differentiated neuronal cell line. Brain Res 2006, 1122:201-208.